The effect of TXYF in alleviating diarrhea may be related to multiple BPs and pathways, such as the inflammatory responses and the immune systems, which are mediated by the TNF signaling pathway, the IL-17 signaling pathway, and the Toll-like receptor (TLR) signaling pathway. The gene discussed is IL17A; the disease is Bartsocas-Papas syndrome 1.